-
Lonza, a Leading CDMO Giant, Announces Permanent Closure and Layoffs
Lonza, one of the world's largest Contract Development and Manufacturing Organizations (CDMOs), recently made headlines with its decision to permanent...
2024-01-22 15:59 -
Cross-Industry Acquisition in the ADC Field: Goodbye Money, Hello Challenges
South Korean food industry giant Lotte Confectionery has made a significant acquisition, purchasing a 25.7% stake in LegoChem Biosciences (LCB), a lea...
2024-01-22 15:56 -
Dramatic Shake-Ups in China's Pharmaceutical Industry: Executives Transitioning from MNCs to Local C...
China's pharmaceutical industry is experiencing a wave of significant transformations as executives from multinational corporations (MNCs) are making ...
2024-01-22 15:51 -
Breaking Boundaries: Novartis Awakens to the Power of ADC and Radiopharmaceuticals
While other major players eagerly pursue antibody-drug conjugates (ADCs), Novartis has set its sights on a different horizon, delving into the realm o...
2024-01-22 15:37 -
Awakening of Small Nucleic Acid Drugs: Will 2024 Become a Landmark Year?
2024 holds promising prospects for small nucleic acid drugs, marking a potential awakening in this field. Recent collaborations and advancements in th...
2024-01-19 16:11 -
The Controversial Billion-Dollar Tuition: The Story Behind Hengrui's BD Dispute
The recent acquisition of AiolosBio by GSK for a staggering $1 billion has sparked controversy surrounding Hengrui Pharmaceuticals' involvement.
2024-01-19 16:02 -
Revolutionizing Drug Delivery: The Rise of Nanotechnology in Medicine
In the realm of medicine, constant advancements and innovations pave the way for improved treatments and patient outcomes.
2024-01-19 15:39 -
Unveiling the Challenges Faced by Biotech Companies in the Pharmaceutical Industry
In the realm of the pharmaceutical industry, biotech companies play a vital role in driving innovation and advancing medical treatments.
2024-01-19 15:26 -
Unveiling the Potential of TIGIT: A Game-Changer in Innovative Medicine
The landscape of innovative medicine is constantly evolving, with researchers pushing the boundaries to develop groundbreaking therapies for various d...
2024-01-19 15:23 -
Johnson & Johnson Announces $2 Billion Acquisition of Ambrx - A Game-Changer in Cancer Treatment
In a groundbreaking move, pharmaceutical giant Johnson & Johnson has confirmed its definitive agreement to acquire Ambrx Biopharma for a staggering $2...
2024-01-19 15:18
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
Related Products